Induction and modulation of inflammatory networks by bacterial protein toxins

The Comprehensive Sourcebook of Bacterial Protein Toxins

Volumn , Issue , 2006, Pages 887-918

  Backert, Steffen ^a   König, Wolfgang ^a   König, Brigitte ^a   Arnold, Ralf ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84857793483     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088445-2/50059-7     Document Type: Chapter

References (280)

1. Abman S.H., Ogle J.W., Butler-Simon N., Rumack C.M., Accurso F.J. Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosis. J. Pediatr. 1988, 113:826-830.
2. Akira S., Takeda K., Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2001, 2:675-680.
3. Allen L.A. Mechanisms of pathogenesis: evasion of killing by polymorphonuclear leukocytes. Microbes Infect. 2003, 5:1329-1335.
4. Allen L.A., Allgood J.A. Atypical protein kinase C-zeta is essential for delayed phagocytosis of Helicobacter pylori. Curr. Biol. 2002, 12:1762-1766.
5. Allen L.A., Schlesinger L.S., Kang B. Virulent strains of Helicobacter pylori demonstrate delayed phagocytosis and stimulate homotypic phagosome fusion in macrophages. J. Exp. Med. 2000, 191:115-128.
6. Amieva M.R., Vogelmann R., Covacci A., Tompkins L.S., Nelson W.J., Falkow S. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 2003, 300:1430-1434.
7. Amorim C.Z., Hastewell J., Walker C.H. Toll-like receptors as potential therapeutic targets for multiple diseases. Nat. Rev. Drug Discovery 2002, 1:797-807.
8. Aoki M., Ono Y., Kunii O., Goldstein E. Effect of newer quinolones on the extra- and intracellular chemiluminescence response of human polymorpho-nuclear leucocytes. J. Antimicrob. Chemother. 1994, 34:383-390.
9. Arbour N.C., Lorenz E., Schutte B.C., Zabner J., Kline J.N., Jones M., Frees K., Watt J.L., Schwartz D.A. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 2000, 25:187-191.
10. Armstrong D., Grimwood K., Carlin J.B., Carzino R., Hull J., Olinsky A., Phelan P.D. Severe viral respiratory infections in infants with cystic fibrosis. Pediatr. Pulmonol. 1998, 26:371-379.
11. Arnold R., König W. Respiratory syncytial virus infection of human lung endothelial cells enhances selectively ICAM-1 expression. J. Immunol. 2005, 174:7359-7367.
12. Arnold R., König W. Peroxisome proliferator-activated, receptor-gamma (PPAR-gamma) ligands possess antiviral and anti-inflammatory activity in the course of respiratory syncytial virus infection. Allergy Clin. Immunol. Int. 2005, (Suppl. 2), 2005, Hogrete and Huber Publishers.
13. Arnold R., König B., Werchau H., König W. Respiratory syncytial virus deficient in soluble G protein induced an increased proinflammatory response in human lung epithelial cells. Virology 2004, 330:384-397.
14. Arnold R., Scheffer J., König B., König W. Effect of Listeria monocytogenes and Yersinia enterocolitica on cytokine gene expression and release from polymorphonuclear granulocytes and human epithelial. Infect. Immun. 1993, 60:2545-2552.
15. Asada K., Sasaki S., Suda T., Chida K., Nakamura H. Anti-inflammatory roles of peroxisome proliferators-activated receptor γ in human alveolar macrophages. Am. J. Respir. Crit. Care Med. 2004, 169:195-200.
16. Backert S., Churin Y., Meyer T.F. Helicobacter pylori type IV secretion, host cell signaling, and vaccine development. Keio J. Med. 2002, 51(Suppl. 2):6-14.
17. Backert S., Kwok T., Schmid M., Selbach M., Moese S., Peek R.M., König W., Meyer T.F., Jungblut P.R. Subproteomes of soluble and structure-bound Helicobacter pylori proteins analyzed by two-dimensional gel electrophoresis and mass spectrometry. Proteomics 2005, 5:1331-1345.
18. Backert S., Moese S., Selbach M., Brinkmann V., Meyer T.F. Phosphorylation of tyrosine 972 of the Helicobacter pylori CagA protein is essential for induction of a scattering phenotype in gastric epithelial cells. Mol. Microbiol. 2001, 42:631-644.
19. Backert S., Schwarz T., Miehlke S., Kirsch C., Sommer C., Kwok T., Gerhard M., Goebel U.B., Lehn N., König W., Meyer T.F. Functional analysis of the cag pathogenicity island in Helicobacter pylori isolates from patients with gastritis, peptic ulcer, and gastric cancer. Infect. Immun. 2004, 72:1043-1056.
20. Baggiolini M. Chemokines in pathology and medicine. J. Intern. Med. 2001, 250:91-104.
21. Baggiolini M., Clark-Lewis I. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett. 1992, 307:97-101.
22. Baker M.D., Acharya K.R. Superantigens: Structure-function relationships. Int. J. Med. Microbiol. 2004, 293:529-537.
23. Barbieri J.T., Riese M.J., Aktories K. Bacterial toxins that modify the actin cytoskeleton. Annu. Rev. Cell. Dev. Biol. 2002, 18:315-344.
24. Becker K., Friedrich A.W., Lubritz G., Weilert M., Peters G., von Eiff C. Prevalence of genes encoding pyrogenic toxin superantigens and exfoliative toxins among strains of Staphylococcus aureus isolated from blood and nasal specimens. J. Clin. Microbiol. 2003, 41:1434-1439.
25. Becker M.N., Sauer M.S., Muhlebach M.S., Hirsh A.J., Wu Q., Verghese M.W., Randell S.H. Cytokine secretion by cystic fibrosis airway epithelial cells. Am. J. Respir. Crit. Care Med. 2004, 169:645-653.
26. Berger M., Budhu S., Lu E., Li Y., Loike D., Silverstein S.C., Loike J.D. Different G(i)-coupled chemoattractant receptors signal qualitatively different functions in human neutrophils. J. Leukoc. Biol. 2002, 71:798-806.
27. Bergmann U., Scheffer J., Köller M., Schönfeld W., Erbs G., Müller F.E., König W. Induction of inflammatory mediators (histamine and leukotrienes) from rat peritoneal mast cells and human granulocytes by Pseudomonas aeruginosa strains from burn patients. Infect. Immun. 1989, 57:2187-2195.
28. Berin M.C., Darfeuille-Michaud A., Egan L.J., Miyamoto Y., Kagnoff M.F. Role of EHEC O157:H7 virulence factors in the activation of intestinal epithelial cell NF-kappaB and MAP kinase pathways and the upregulated expression of interleukin 8. Cell. Microbiol. 2002, 4:635-648.
29. Beutler B. Inferences, questions, and possibilities in Toll-like receptor signaling. Nature 2004, 430:257-263.
30. Bishop A.L., Hall A. Rho GTPases and their effector proteins. Biochem. J. 2000, 348:241-255.
31. Black D.S., Bliska J.B. The RhoGAP activity of the Yersinia pseudotuberculosis cytotoxin YopE is required for antiphagocytic function and virulence. Mol. Microbiol. 2000, 37:515-527.
32. Black H.R., Yankaskas J.R., Johnson L.G., Noah T.L. IL-8 production by cystic fibrosis nasal epithelial cells after tumor necrosis factor alpha and respiratory syncytial virus stimulation. Am. J. Respir. Cell. Mol. Biol. 1998, 19:210-215.
33. Bodger K., Crabtree J.E. Helicobacter pylori and gastric inflammation. Br. Med. Bull. 1998, 54:139-150.
34. Boncristiano M., Paccani S.R., Barone S., Ulivieri C., Patrussi L., Ilver D., Amedei A., D'Elios M.M., Telford J.L., Baldari C.T. The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms. J. Exp. Med. 2003, 198:1887-1897.
35. Boone D.L., Turer E.E., Lee E.G., Ahmad R.C., Wheeler M.T., Tsui C., Hurley P., Chien M., Chai S., Hitotsumatsu O., McNally E., Pickart C., Ma A. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat. Immunol. 2004, 5:1052-1060.
36. Boquet P. Lemichez E. Bacterial virulence factors targeting Rho GTPases: parasitism or symbiosis?. Trends Cell. Biol. 2003, 13:238-246.
37. Bouchon A., Facchetti F., Weigand M.A., Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001, 410:1103-1107.
38. Boyle E.C., Finlay B.B. Bacterial pathogenesis: exploiting cellular adherence. Curr. Opin. Cell. Biol. 2003, 15:633-639.
39. Brandt S., Kwok T., Hartig R., König W., Backert S. Potentiation of pro-inflammatory responses by the Helicobacter pylori CagA protein 2004, Submitted.
40. Brandtzaeg P., Pabst R. Let's go mucosal: communication on slippery ground. Trends Immunol. 2004, 25:570-577.
41. Brom C., Brom J., König W. GTPases and low molecular weight G-proteins during cell-cell interaction between neutrophils and platelets. Int. Arch. All. Appl. Immunol. 1992, 99:397-399.
42. Brom J., König W. Cytokine-induced (IL-3, IL-6, IL-8, and TNF&) activation and deactivation of human neutrophils. Immunology 1992, 75:281-285.
43. Brom J., Köller M., Müller-Lange P.M., Steinau H.U., König W. GTP-binding proteins in polymorphonuclear granulocytes of severely burned patients. J. Leukoc. Biol. 1993, 53:268-272.
44. Burns D.L., Barbieri J.T., Iglewski B.H., Rapppuoli R. Bacterial Protein Toxins 2003, ASM Press.
45. Campbell D.E., Kemp A.S. Proliferation and production of interferon-gamma (IFN-gamma) and IL-4 in response to Staphylococcus aureus and staphylococcal superantigen in childhood atopic dermatitis. Clin. Exp. Immunol. 1997, 107:392-397.
46. Cannon C.L., Kowalski M.P., Stopak K.S., Pier G.B. Pseudomonas aeruginosa-induced apoptosis is defective in respiratory epithelial cells expressing mutant cystic fibrosis transmembrane conductance regulator. Am. J. Respir. Cell. Mol. Biol. 2003, 29:188-197.
47. Chambers H.F. The changing epidemiology of Staphylococcus aureus?. Emerg. Infect. 2001, 7:178-182.
48. Chen L.F., Greene W.C. Shaping the nuclear action of NF-kappaB. Nat. Rev. Mol. Cell. Biol. 2004, 5:392-401.
49. Chimini G., Chavrier P. Function of Rho family proteins in actin dynamics during phagocytosis and engulfment. Nat. Cell. Biol. 2000, 2:E191-E196.
50. Chmiel J.F., Berger M., Konstan M.W. The role of inflammation in the pathophysiology of CF lung disease. Clin. Rev. in Allergy and Immunol. 2002, 23:5-27.
51. Chow C.W., Abreu M.T.H., Suzuki T., Downey G.P. Oxidative stress and acute lung injury. Am. J. Respir. Cell. Mol. Biol. 2003, 29:427-431.
52. Cook D.N., Psietsky D.S., Schwartz D.A. Toll-like receptors in the pathogenesis of human disease. Nat. Immunol. 2004, 5:975-979.
53. Cossart P., Sansonetti P.J. Bacterial invasion: the paradigms of enteroinvasive pathogens. Science 2004, 304:242-248.
54. Covacci A., Telford J.L., Del Giudice G., Parsonnet J., Rappuoli R. Helicobacter pylori virulence and genetic geography. Science 1999, 284:1328-1333.
55. Cross M.J., Welsh L.C. FGF and VEGF function in angiogenesis: signaling pathways, biological responses, and therapeutic inhibition. Trends Pharmacol. Sci. 2001, 22:201-207.
56. Dai Y., Dean T.P., Church M.K., Warner J.O., Shute J.K. Desensitisation of neutrophil responses by systemic interleukin 8 in cystic fibrosis. Thorax 1994, 49:867-871.
57. Dalton J.E., Howell G., Pearson J., Scott P., Carding S.R. Fas-Fas Ligand interactions are essential for the binding to and killing of activated macrophages by γδT Cells. J. Immunol. 2004, 173:3660-3667.
58. Dayer P.F., Schlegel-Haueter S.E., Belli D.C., Rochat T., Dudez T.S., Suter S. Cystic fibrosis and the pseudomonads. J. Infect. Dis. 1998, 177:1413-1417.
59. De Gregorio E., Rappuoli R. Inside sensors detecting outside pathogens. Nat. Immunol. 2004, 5:1099-1100.
60. De Haan L., Hirst T.R. Cholera toxin: a paradigm for multi functional engagement of cellular mechanisms (Review). Mol. Membr. Biol. 2004, 21:77-92.
61. Deng J.C., Zeng X., Newstead M., Moore T.A., Tsai W.C., Thannickal V.J., Standiford T.J. STAT4 is a critical mediator of early innate immune responses against pulmonary Klebsiella infection. J. Immunol. 2004, 173:4075-4083.
62. Devaney J.M., Greene C.M., Taggart C.C., Carroll T.P., O'Neill S.J., McElvaney N.G. Neutrophil elastase up-regulates interleukin-8 via toll-like receptor 4. FEBS Lett. 2003, 544:129-132.
63. Devine D.A. Antimicrobial peptides in defense of the oral and respiratory tracts. Mol. Immunol. 2003, 40:431-443.
64. Diamond G., Legarda D., Ryan L.K. The innate immune response of the respiratory epithelium. Immunol. Rev. 2000, 173:27-38.
65. κB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells. J. Clin. Invest. 1998, 101:2598-2605.
66. Dinges M.M., Orwin P.M., Schlievert P.M. Exotoxins of Staphylococcus aureus. Clin. Microbiol. Rev. 2000, 13:16-34.
67. Dragneva Y., Anuradha C.D., Valeva A., Hoffmann A., Bhakdi S., Husmann M. Subcytocidal attack by staphylococcal alpha-toxin activates NF-kappaB and induces interleukin-8 production. Infect. Immun. 2001, 69:2630-3635.
68. Drynda A., König B., Bonventre P.F., König W. Role of a carboxy-terminal site of toxic shock syndrome toxin 1 in eliciting immune responses of human peripheral blood mononuclear cells. Infect. Immun. 1995, 63:1095-1101.
69. Duesbery N.S., Webb C.P., Leppla S.H., Gordon V.M., Klimpel K.R., Copeland T.D., Ahn N.G., Oskarsson M.K., Fukasawa K., Paull K.D., Vande Woude G.F. Proteolytic inactivation of MAP kinase kinase by anthrax lethal factor. Science 1998, 280:734-737.
70. Dunzendorfer S., Lee H.K., Soldau K., Tobias P.S. TLR4 is the signaling but not the lipopolysaccharide uptake receptor. J. Immunol. 2004, 173:1166-1170.
71. Enarsson K., Innocenti-Brisslert M., Backert S., Quiding-Järbrink M. Helicobacter pylori induce transendothelial migration of activated memory T cells. Infect. Immun. 2005, 73:761-769.
72. Enright M.C., Day N.P., Davies C.E., Peacock S.J., Spratt B.G. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J. Clin. Microbiol. 2000, 38:1008-1015.
73. Enright M.C., Robinson D.A., Randle G., Feil E.J., Grundmann H., Spratt B.G. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc. Natl. Acad. Sci. USA 2002, 99:7687-7692.
74. Epelman S., Stack D., Bell C., Wong E., Neely G.G., Krutzik S., Miyake K., Kubes P., Zbytnui L.D., Ma L.L., Xie X., Woods D.E., Mody CH. Different domains of Pseudomonas aeruginosa exoenzyme S activate distinct TLRs. J. Immunol. 2004, 173:2031-2040.
75. Eriksson S., Bjorkman J., Borg S., Syk A., Pettersson S., Andersson D.I., Rhen M. Salmonella typhimurium mutants that downregulate phagocyte nitric oxide production. Cell. Microbiol. 2000, 2:239-250.
76. Esmon C.T. Interactions between the innate immune and blood coagulation systems. Trends Immunol. 2004, 25:536-542.
77. Falnes P.O., Sandvig K. Penetration of protein toxins into cells. Curr. Opin. Cell. Biol. 2000, 12:407-413.
78. Fasano A., Nataro J.P. Intestinal epithelial tight junctions as targets for enteric bacteria-derived toxins. Adv. Drug. Deliv. Rev. 2004, 56:795-807.
79. Finlay B.B., Falkow S. Common themes in microbial pathogenicity revisited. Microbiol. Mol. Biol. Rev. 1997, 61:136-169.
80. Firoved A.M., Ornatowski W., Deretic V. Microarray analysis reveals induction of lipoprotein genes in mucoid Pseudomonas aeruginosa: implications for inflammation in cystic fibrosis. Infect. Immun. 2004, 72:5012-5018.
81. Fischer S., Adam D. Effects of moxifloxacin on neutrophil phagocytosis, burst production, and killing as determined by a whole-blood cytofluorometric Method. Antimicrob. Agents Chemother. 2001, 45:2668-2669.
82. Frandji P., Tkaczyk C., Oskeritzian C., David B., Desaymard C., Mécheri S. Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes. Eur. J. Immunol. 1996, 26:2517-2528.
83. Galan J.E., Collmer A. Type III secretion machines: bacterial devices for protein delivery into host cells. Science 1999, 284:1322-1328.
84. Galli S.J. The Paul Kallos Memorial Lecture. The mast cell: a versatile effector cell for a challenging world. Int. Arch. Allergy Immunol. 1997, 113:14-22.
85. Gao L.Y., Kwaik Y.A. The modulation of host cell apoptosis by intracellular bacterial pathogens. Trends Microbiol. 2000, 8:306-313.
86. Gebert B., Fischer W., Weiss E., Hoffmann R., Haas R. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 2003, 301:1099-1102.
87. Gemmell C.G. Antibiotics and neutrophil function-potential immunomodulating activities. J. Antimicrob. Chemother. 1993, 31:B 23-B 33. (Suppl.).
88. Ghebremedhin B., König W., König B. Heterogeneity of methicillin-resistant Staphylococcus aureus strains at a German University Hospital during a one year period. Eur. J. Clin. Microbiol. Infect. Dis. 2005, 24:388-398.
89. Gieseler S., König B., König W., Backert S. Strain-specific expression profiles of virulence genes in Helicobacter pylori during infection of gastric epithelial cells and granulocytes 2005, 7:437-447.
90. Girardin S.E., Boneca I.G., Carneiro L.A., Antignac A., Jehanno M., Viala J., Tedin K., Taha M.K., Labigne A., Zahringer U., Coyle A.J., DiStefano P.S., Bertin J., Sansonetti P.J., Philpott D.J. Nod1 detects a unique muropeptide from Gram-negative bacterial peptidoglycan. Science 2003, 300:1584-1587.
91. Gobert A.P., McGee D.J., Akhtar M., Mendz G.L., Newton J.C., Cheng Y., Mobley H.L., Wilson K.T. Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc. Natl. Acad. Sci. USA 2001, 98:13844-13849.
92. Gouaux E., Hobaugh M., Song L. Alpha-hemolysin, gamma-hemolysin, and leukocidin from Straphylococcus aureus: distant in sequence but similar in structure. Protein Sci. 1997, 6:2631-2635.
93. Griese M., Ramakers J., Krasselt A., Starosta V., von Koningsbruggen S., Fischer R., Ratjen F., Müllinger B., Huber R.M., Maier K., Rietschel E., Scheuch G. Improvement of alveolar glutathione and lung function but not oxidative state in cystic fibrosis. Am. J. Respir Crit. Care. Med. 2004, 169:822-828.
94. Gröner M., Scheffer J., König W. Modulation of leukotriene generation by invasive bacteria. Immunology 1992, 77:400-407.
95. Gutierrez O., Pipaon C., Inohara N., Fontalba A., Ogura Y., Prosper F., Nunez G., Fernandez-Luna J.L. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation. J. Biol. Chem. 2002, 277:41701-41705.
96. Hadjivassiliou M., Williamson C.A., Woodroofe N. The immunology of gluten sensitivity: beyond the gut. Trends Immunol. 2004, 25:578-582.
97. Haehnel V., Schwarzfischer L., Fenton M.J., Rehli M. Transcriptional regulation of the human toll-like receptor 2 gene in monocytes and macrophages. J. Immunol. 2002, 168:5629-5637.
98. Hajjar A.M., Ernst R.K., Tsai J.H., Wilson C.B., Miller S.I. Human toll-like receptor 4 recognizes host-specific LPS modifications. Nat. Immunol. 2002, 3:354-359.
99. Hashimoto S., Kobayashi A., Kooguchi K., Kitamura Y., Onodera H., Nakajima H. Upregulation of two death pathways of perforin/granzyme and FasL/Fas in septic acute respiratory Distress Syndrome. Am. J. Respir. Crit. Care. Med. 2000, 161:237-243.
100. Hauf N., Chakraborty T. Suppression of NF-kappa B activation and pro-inflammatory cytokine expression by Shiga toxin-producing Escherichia coli. J. Immunol. 2003, 170:2074-2082.
101. Henderson B., Poole S., Wilson M. Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol. Rev. 1996, 60:316-341.
102. Hensler T., Köller M., Alouf J.E., König W. Toxic Shock Syndrome toxin 1 and the erythrogenic toxin A modulate the chemotactic response of human neutrophils. Infect. Immun. 1993, 58:1055-1061.
103. Hensler T., Köller M., Prévost G., Piémont Y., König W. GTP-binding proteins are involved in the modulated activity of human neutrophils treated with the Panton-Valentine leukocidin from Staphylococcus aureus. Infect. Immun. 1994, 62:5281-5289.
104. Hensler T., König B., Prévost G., Piémont Y., Köller M., König W. Leukotriene B4-generation and DNA fragmentation induced by leukocidin from Staphylococcus aureus: protective role of granulocyte-macrophage colony-stimulating factor (GMCSF) and G-CSF on human neutrophils. Infect. Immun. 1994, 62:2529-2535.
105. Hensler T., Köller M., Alouf J.E., König W. Bacterial toxins induce heat sock proteins in human neutrophils. Biochem. Biophys. Res. Commun. 1991, 179:872-879.
106. Hiatt P.W., Grace S.C., Kozinetz C.A., Raboudi S.H., Treece D.G., Taber L.H., Piedra P.A. Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis. Pediatrics 1999, 103:619-626.
107. Hoebe K., Janssen E., Beutler B. The Interface between innate and adaptive immunity. Nat. Immunol. 2004, 5:971-974.
108. Hofer M.F., Lester M.R., Schlievert P.M., Leung D.Y. Upregulation of IgE synthesis by staphylococcal toxic shoch syndrome toxin-1 in peripheral blood mononuclear cells from patients with atopic dermatitis. Clin. Exp. Allergy. 1995, 25:1218-1227.
109. Hollenbach E., Neumann M., Vieth M., Roessner A., Malfertheiner P., Naumann M. Inhibition of p38 MAP kinase- and RICK/NF-kB-signaling suppresses inflammatory bowel disease. Faseb J. 2004, 18:1550-1552.
110. Holst P.J., Rosenkilde M.M. Microbiological exploitation of the chemokine system. Microbes Infect. 2003, 5:179-187.
111. Hornef M.W., Wick M.J., Rhen M., Normark S. Bacterial strategies for overcoming host innate and adaptive immune responses. Nat. Immunol. 2002, 3:1033-1040.
112. Horng T., Barton G.M., Flavell R.A., Medzhitov R. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 2002, 420:329-333.
113. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., Takeda K., Akira S. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 1999, 162:3749-3752.
114. Howard A.D., McAllister G., Feighner S.D., Liu Q., Nargund R.P., Van der Ploeg L.H.T., Patchett A.A. Orphan G-protein-coupled receptors and natural ligand discovery. Trends Pharmakol. Sci. 2001, 22:132-140.
115. Ishihara S., Rumi M.A.K., Kadowaki Y., Ortega-Cava C.F., Yuki T., Yoshino N., Miyaoka Y., Kazumori H., Ishimura N., Amano Y., Kinoshita Y. Essential role of MD-2 in TLR4-dependent signaling during Helicobacter pylori-associate gastritis. J. Immunol. 2004, 173:1406-1416.
116. Iwasaki A., Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 2004, 5:987-995.
117. Iyer S.S., Barton J.A., Bourgoin S., Kusner D.J. Phospholipases D1 and D2 coordinately regulate macrophage phagocytosis. J. Immunol. 2004, 173:2615-2623.
118. Jaeger K.E., Kinscher D.A., König B., König W. Extracellular lipase of pseudomonas aeruginosa: Biochemistry and potential role as a virulence factor. European Congress of Cystic Fibrosis 1992, 113-119. Pedersen, Hoiby (Eds.).
119. Janeway C.A. Approaching the asymptote? Evolution and revolution in immunology. Cold. Spring. Harb. Symp. Quant. Biol. 1989, 54:1-13.
120. Jarraud S., Mougel C., Thioulouse J., Lina G., Meunier H., Forey F., Nesme X., Etienne J., Vandenesch F. Relationships between Staphylococcus aureus genetic background, virulence factors, agr type (alleles), and human disease type. Infect. Immun. 2002, 70:631-641.
121. Jarraud S., Peyrat M.A., Lim A., Tristan A., Bes M., Mougel C., Etienne J., Vandenesch F., Bonneville M., Lina G. Phylogenetic analysis of enterotoxin genes indicated that they all potentially derived from this cluster, identifying egc as a putative nursery of exterotoxin genes. J. Immunol. 2001, 166:669-677.
122. Ji G., Beavis R., Novick R.P. Bacterial interference caused by autoinducing peptide variants. Science 1997, 276:2027-2030.
123. Just I., Selzer J., Wilm M., von Eichel-Streiber C., Mann M., Aktories K. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 1995, 375:500-503.
124. Kagnoff M.F., Eckmann L. Epithelial cells as sensors for microbial infection. J. Clin. Invest. 1997, 100:6-10.
125. Kahl B.C., Becker K., Friedrich A.W., Clasen J., Bhanu S., von Eiff C., Peters G. Agr-dependent bacterial interference has no impact on long-term colonization of Staphylococcus aureus during persistent airway infection of cystic fibrosis patients. J. Clin. Microbiol. 2003, 41:5199-5201.
126. Kahl B.C., Belling G., Reichelt R., Herrmann M., Proctor R.A., Peters G. Thymidine-dependent small-colony variants of Staphylococcus aureus exhibit gross morphological and ultra-structural changes consistent with impaired cell separation. J. Clin. Microbiol. 2003, 41:410-413.
127. Kanaoka Y., Boyce J.A. Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses. J. Immunol. 2004, 173:1503-1510.
128. Kao C.Y., Chen Y., Thai P., Wachi S., Huang F., Kim C., Harper R.W., Wu R. IL-17 markedly up-regulates β-defensin-2 expression in human airway epithelium via JAK and NF-kB signaling pathways. J. Immunol. 2004, 173:3482-3491.
129. Kaufmann S.H.E., Medzhitov R., Gordon S. The Innate Immune Response to Infection 2004, ASM Press, Washington, DC.
130. Kawei T., Sato S., Ishii K.J., Coban C., Hemmi H., Yamamoto M., Terai K., Matsuda M., Inoue J-i., Uematsu S., Takeuchi O., Akira S. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat. Immunol. 2004, 5:1061-1068.
131. Kayal S., Lilienbaum A., Join-Lambert O., Li X., Israel A., Berche P. Listerolysin O secreted by Listeria monocytogenes induces NF-kappaB signaling by activating the IkappaB kinase complex. Mol. Microbiol. 2002, 44:1407-1419.
132. Kelsall B.L., Rescigno M. Mucosal dendritic cells in immunity and inflammation. Nat. Immunol. 2004, 5:1091-1095.
133. Kerr J.R. Cell adhesion molecules in the pathogenesis of and host defense against microbial infection. Mol. Pathol. 1999, 52:220-230.
134. Kimata H., Fujimoto M., Ishioka C., Yoshida A. Histamine selectively enhances human immunoglobulin E (iGE) and IgG4 production induced by anti-CD58 monoclonal antibody. J. Ex. Med. 1996, 184:357-364.
135. Knodler L.A., Celli J., Finlay B.B. Pathogenic trickery: deception of host cell processes. Nat. Rev. Mol. Cell. Biol. 2001, 2:578-588.
136. Köller M., Brom J., König W. Analysis of 5-lipoxygenase and 5-lipoxygenase activating protein in neutrophil granulocytes of severely burned patients. Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury 1993, 759-761. Academic Press, Washington, DC. S. Nigam, C.W. Honn, T. Walden, Kluwer (Eds.).
137. König B., König W. Role of protein kinase C and G-proteins in human peripheral blood leukocytes on inflammatory mediator release by genetically cloned E. coli strains (hemolysin +/-; adhesins +/-). Infect. Immun. 1991, 59:3801-3810.
138. König B., König W. Induction and suppression of cytokine release (tumor necrosis factor-alpha; interleukin-6; interleukin 1β) by Escherichia coli pathogenicity factors (adhesins, alpha-hemoylsin). Immunology 1993, 78:526-533.
139. König B., König W. The fluoroquinolone Moxifloxacin modulates neutrophil chemotaxis 2005, Submitted.
140. König B., Jaeger K.E., Sage A.E., Vasil M.L., König W. Role of Pseudomonas aeruginosa lipase in inflammatory mediator release from human inflammatory effector cells (platelets, granulocytes, and monocytes). Infect. Immun. 1996, 64:3252-3258.
141. König B., Köller M., Prévost G., et al. Activation of effector cells by different bacterial toxins (leukocidin, alveolysin, erythrogenic toxin A), generation of interleukin-8. Infect. Immun. 1994, 62:4831-4837.
142. König B., König W., Arnold R., Werchau H., Ihorst G., Forster J. Prospective study of human metapneumovirus infection in children less than three years of age. J. Clin. Microbiol. 2004, 42:4632-4635.
143. König B., Ludwig A., Goebel W., König W. Pore formation by the Escherichia coli α-hemolysin: role for mediator release from human inflammatory cells. Infect. Immun. 1994, 63:4612-4617.
144. König B., Prévost G., König W. Composition of staphylococcal bi-component toxins determines pathophysiological reactions. J. Med. Microbiol. 1997, 46:479-485.
145. König B., Prévost G., Piémont Y., König W. Effects of Staphyloccus aureus leukocidins on inflammatory mediator release from human granulocytes. J. Infect. Dis. 1995, 171:607-613.
146. König B., Tammer I., Sollich V., König W. Intra- and interpatient variability of the hsp65 and 16S-23S intergenic gene region in Mycobacterium abscessus strains from Cystic Fibrosis patients 2004, Submitted.
147. König B., Vasil M.L., König W. Role of hemolytic and non-hemolytic phospholipase C from Pseudomonas aeruginosa in intelreukin-8 release from human monocytes. J. Med. Microbiol. 1997, 46:471-478.
148. König W., Fischer U., Stephan Th., Bujanowski-Weber J. Regulation of CD23 in allergic disease. Monographs in Allergy-CD23, a novel multifunctional regulator of the immune system 1991, 94-123. Karger, Boston. J. Gordon (Ed.).
149. König W., Köller M., Brom J. Priming mechanisms and induction of heat shock proteins in human polymorphonuclear granulocytes induced by eicosanoids and cytokines. Eisosanoids 1992, 5:539-541.
150. König W., Schönfeld W., Raulf M., Köller M., Knöller J., Scheffer J., Brom J. The neutrophil and leukotrienes' role in health and disease. Eicosanoids 1990, 3:1-22.
151. Kotone-Miyahara Y., Yamashita K., Lee K., Yonehara S., Uchiyama T., Sasada M., Takashashi A. Short-term delay of Fas-stimulated apoptosis by GM-CSF as a result of temporary suppression of FADD recruitment in neutrophils: evidence implicating phosphatidylinositol 3-kinase and MEK1/2 pathways downstream of classical protein kinase C. J. Leukoc. Biol. 2004, 76:1047-1056.
152. Kotwal G.J. Microorganisms and their interaction with the immune system. J. Leukoc. Biol. 1997, 62:415-429.
153. Krell S., Adams I., Arnold U., Kalinski T., Aumann V., König W., König B. Influenza B pneumonia with Staphylococcus aureus superinfection associated with Parvovirus B19 and concomitant agranulocytosis. Infection 2003, 5:353-358.
154. Kunkel S.L., Lukacs N.W., Strieter R.M., Chensue S.W. The role of chemokines in the immunopathology of pulmonary disease. Forum (Genova) 1999, 9:339-355. Review.
155. Kwok T., Backert S., Schwarz H., Berger J., Meyer T.F. Specific entry of Helicobacter pylori into cultured gastric epithelial cells via a zipper-like mechanism. Infect. Immun. 2002, 70:2108-2120.
156. Labro M.T. Interaction of macrolides and quinolones with the host defense system. Eur. Bull. Drug. Res. 1993, 2(Suppl. 1):7-13.
157. Labro M.T. Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?. Clin. Microbiol. Rev. 2000, 13:615-650.
158. Lazarus R., Raby B.A., Lange C., Silverman E.K., Kwiatkowski D.J., Vercelli D., Klimecki W.J., Martinez F.D., Weiss S.T. Toll-like receptor 10 genetic variation is associated with asthma in two independent samples. Am. J. Respir. Crit. Care. Med. 2004, 170:594-600.
159. Lee S.K., Stack A., Katzowitsch E., Aizawa S.I., Suerbaum S., Josenhans C. Helicobacter pylori flagellins have very low intrinsic activity to stimulate human gastric epithelial cells via TLR5. Microbes Infect. 2003, 5:1345-1356.
160. Leung D.Y. Molecular basis of allergic diseases. Mol. Genet. Metab. 1998, 63:157-167.
161. Levy O. Antimicrobial proteins and peptides: anti-infective molecules of mammalian leukocytes. J. Leukoc. Biol. 2004, 76:909-925.
162. Li H., Llera A., Mariuzza R.A. Structure-function studies of T cell receptor superantigen interactions. Imm. Rev. 1998, 163:177-186.
163. Li Y., Li H., Dimasi N., McCormick J.K., Martin R., Schuck P., Schlievert P.M., Mariuzza R.A. Crystal structure of a superantigen bound to the high-affinity, zinc-dependent site on MHC class II. Immunity 2001, 14:93-104.
164. Lin T.J., Maher L.H., Gomi K., McCurdy J.D., Garduno R., Marshall J.S. Selective early production of CCL20, or macrophage inflammatory protein 3alpha, by human mast cells in response to Pseudomonas aeruginosa. Infect. Immun. 2003, 71:365-373.
165. Lina G., Boutite F., Tristan A., Bes M., Etienne J., Vandenesch F. Bacterial competition for human nasal cavity colonization: role of Staphylococcal agr alleles. Appl. Envir. Microbiol. 2003, 69:18-23.
166. Lina G., Piémont Y., Godail-Gamot F., Bes M., Peter M.O., Gauduchon V., Vandenesch F., Etienne J. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin. Infect. Dis. 1999, 29:1128-1132.
167. Liston A., McColl S. Subversion of the chemokine world by microbial pathogens. Bioessays. 2003, 25:478-488.
168. Loetscher P., Clark-Lewis I. Agonistic and antagonistic activities of chemokines. J. Leukoc. Biol. 2001, 69:881-884.
169. Lorenz E., Chemotti D.C., Vandal K., Tessier P.A. Toll-like receptor 2 represses nonpilus adhesin-induced signaling in acute infections with the Pseudomonas aeruginosa pilA mutant. Infect. Immun. 2004, 72:4561-4569.
170. Mack D.M., Haeder M., Siemssen N., Laufs R. Association of biofilm production of coagulase-negative staphylococci with expression of a specific polysaccharide intercellular adhesin. J. Inf. Dis. 1996, 174:881-884.
171. Mackay C.R. Chemokines: immunology's high impact factors. Nat. Immunol. 2001, 2:95-101.
172. MacMicking J.D. IFN-inducible GTPases and immunity to intracellular pathogens. Trends Immunol. 2004, 25:601-609.
173. Maggi E. The Th1/Th2 paradigm in allergy. Immunotechnol. 1998, 3:233-244.
174. Mahalingam S., Karupiah G. Chemokines and chemokine receptors in infectious diseases. Immunol. Cell. Biol. 1999, 77:469-475.
175. Mantovani A., Bussolino F., Introna M. Cytokine regulation of endothelial cell function: from molecular level to the bedside. Immunol. Today 1997, 18:231-239.
176. Marinissen M.J., Gutkind J.S. G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol. Sci. 2001, 22:368-375.
177. Maus U.A., Srivastava M., Paton J.C., Mack M., Everhart M.B., Blackwell T.S., Christman J.W., Schlönforff D., Seeger W., Lohmeyer J. Pneumolysin-induced lung injury is independent of leukocyte trafficking into the alveolar space. J. Immunol. 2004, 173:1307-1312.
178. McCormick J.M., Yarwood J.M., Schlievert P.M. Toxic shock syndrome and bacterial superantigens: an update. Annu. Rev. Microbiol. 2001, 55:77-104.
179. Mécheri S., David B. Unravelling the mast cell dilemma: culprit or victim of its generosity?. Immunol. Today 1997, 18:212-215.
180. Medzhitov R., Janeway C. Innate immunity. New Engl. J. Med. 2000, 343:338-344.
181. Merrell D.S., Falkow S. Frontal and stealth attack strategies in microbial pathogenesis. Nature 2004, 430:250-256.
182. Middleton P.G., Pollard K.A., Donohoo E., Wheatley J.R., Geddes D.M. Airway surface liquid calcium modulates chloride permeability in the cystic fibrosis airway. Am. J. Respir. Crit. Care. Med. 2003, 168:1223-1226.
183. Mimuro H., Suzuki T., Tanaka J., Asahi M., Haas R., Sasakawa C. Grb2 is a key mediator of Helicobacter pylori CagA protein activities. Mol. Cell. 2002, 10:745-755.
184. + Helicobacter pylori induces homotypic aggregation of macrophage-like cells by up-regulation and recruitment of intracellular adhesion molecule 1 to the cell surface. Infect. Immun. 2002, 70:4687-4691.
185. Monack D.M., Mueller A., Falkow S. Persistent bacterial infections: the interface of the pathogen and the host immune system. Nat. Rev. Microbiol. 2004, 2:747-765.
186. Montecucco C., Rappuoli R. Living dangerously: how Helicobacter pylori survives in the human stomach. Nat. Rev. Mol. Cell. Biol. 2001, 2:457-466.
187. Montecucco C., De Bernard M., Papini E., Zoratti M. Helicobacter pylori vacuolating cytotoxin: cell intoxication and anion-specific channel activity. Curr. Top. Microbiol. Immunol. 2001, 257:113-129.
188. Moser C., Johansen H.K., Song Z., Hougen H.P., Rygaard J., Hoiby N. Chronic Pseudomonas aeruginosa lung infection is more severe in Th2 responding BALB/c mice compared to Th1 responding C3H/HeN mice. APMIS 1997, 105:838-842.
189. Muir A., Soong G., Sokol S., Reddy B., Gomez M.I., Van Heeckeren A., Prince A. Toll-like receptors in normal and cystic fibrosis airway epithelial cells. Am. J. Respir. Cell. Mol. Biol. 2004, 30:777-783.
190. Müllbacher A., Regner M., Wang Y., Lee E., Lobigs M., Simon M. Can we really learn from model pathogens?. Trends Immunol. 2004, 25:524-528.
191. Müller M., Stass H., Brunner M., Möller J.G., Lackner E., Eichler H.G. Penetration of moxifloxacin into peripheral compartments in humans. Antimicrob. Agents Chemother. 1999, 43:2345-2349.
192. Müller-Alouf H., Alouf J.E., Gerlach D., Ozegowski J.H., Fitting C., Cavaillon J.M. Human pro- and anti-inflammatory cytokine patterns induced by Streptococcus pyogenes erythrogenic (pyrogenic) exotoxin A and C superantigens. Infect. Immun. 1996, 64:1450-1453.
193. Müller-Alouf H., Gerlach D., Desreumaux P., Leportier C., Alouf J.E., Capron M. Streptococcal pyrogenic exotoxin A (SPE A) superantigen-induced production of hematopoietic cytokines, IL-12 and IL-13, by human peripheral blood mononuclear cells. Microb. Pathog. 1997, 23:265-272.
194. murphy G.J., Holder J.C. PPAR& agonists: therapeutic role in diabetes, inflammation and cancer. TIPS 2000, 21:469-474.
195. Muzio M., Bosisio D., Polentarutti N., D'amico G., Stoppacciaro R., Mancinelli C., van't Veer G., Penton-Rol L.P., Ruco P.Allavena, Mantovani A. Differential expression and regulation of Toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J. Immunol. 2000, 164:5998-6004.
196. Nagata S. Apoptosis by death factor. Cell 1997, 88:355-365.
197. Neuber K., König W. Effects of Staphylococcus aureus cell wall products (teichoic acid, peptidoglycan) and enterotoxin B on immunoglobulin (IgE, IgA, IgE) synthesis and CD23 expression in patients with atopic dermatitis. Immunology 1992, 75:23-28.
198. Neuber K., Hilger R.A., König W. Interleukin-3, Interleukin-8, FMLP, and C5a enhance the release of leukotrienes from neutrophils of patients with atopic dermatitis. Immunology 1991, 73:197-204.
199. Neuber K., Hilger R.A., König W. Differential Increase in 12-HETE release and CD29/CD49f expression of platelets from normal donors and from patients with atopic dermatitis by Staphylococcus aureus. Int. Arch. All. Appl. Immunol. 1992, 98:339-342.
200. Neuber K., Stephan U., Fränken J., König W. Staphylococcus aureus modifies the cytokine-induced immunoglobulin synthesis and CD23 expression in patients with atopic dermatitis. Immunology 1991, 73:197-204.
201. Nikolaidis N.M., Zimmermann N., King N.E., Mishra A., Pope S.M., Finkelman F.D., Rothenberg M.E. Trefoil Factor-2 is an allergen-induced gene regulated by Th2 cytokines and STAT6 in the lung. Am. J. Respir. Cell. Mol. Biol. 2003, 29:458-464.
202. Novick R.P. Pathogenicity factors and their regulation. Gram-Positive Pathogens 2000, 392-407. American Society for Microbiology, Basel. V.A. Fischetti, R.P. Novick, J.J. Ferretti, D.A. Portnoy, J.I. Rood (Eds.).
203. Novick R.P., Schlievert P., Ruzin A. Pathogenicity islands of staphylococci. Microbes Infect. 2001, 3:585-594.
204. Oliveira D.C., de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 2002, 36:2155-2161.
205. Omoe K., Ishikawa M., Shimoda Y., Hu D.L., Ueda S., Shinagawa K. Detection of seg, seh, and sei genes in Staphylococcus aureus isolates and determination of the enterotoxin productivities of S aureus isolates harboring seg, seh, or sei genes. J. Clin. Microbiol 2002, 40:857-862.
206. Papageorgiou A.C., Quinn C.P., Beer D., Brehm RD., Tranter H.S., Bonventre P.F. Crystal structure of a biologically inactive mutant of toxic shock syndrome toxin-1 at 25A resolution. Protein Sci. 1996, 5:1737-1741.
207. Park H.S., Jung H.Y., Kim J., Lee W.J., Bae Y.S. Cutting edge: Direct interaction of TLR 4 with NAD(P) H Oxidase 4 Isozyme is essential for Lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kB. J. Immunol. 2004, 173:3589-3593.
208. Peek R.M., Blaser M.J. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer 2002, 2:28-37.
209. Perez-Perez G.I., Shepherd V.L., Morrow J.D., Blaser M.J. Activation of human THP-1 cells and rat bone marrow-derived macrophages by Helicobacter pylori lipopolysaccharide. Infect. Immun. 1995, 63:1183-1187.
210. Peters G., Locci R., Pulverer G. Microbial colonization of prosthetic divices. II. Scanning electron microscopy of naturally infected intravenous catheters. Zentralbl. Bakteriol. Microbiol. Hyg. B. 1981, 173:293-299.
211. Petersson K., Forsberg G., Walse B. Interplay between superantigens and immunoreceptors. Scandinavian J. Immunol. 2004, 59:345-355.
212. Petersson K., Hakansson M., Nilsson H., Forsberg G., Svensson L.A., Liljas A., Walse B. Crystal structure of a superantigen bound to MHC class II displays zinc and peptide dependence. EMBO J. 2001, 20:3306-3312.
213. Petersson K., Pettersson H., Skartved N.J., Walse B., Forsberg G. Staphylococcal enterotoxin H induces V alpha-specific expansion of T cells. J. Immunol. 2003, 170:4148-4154.
214. Pier G.B., Grout M., Zaidi T.S. Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung. Proc. Natl. Acad. Sci. USA. 1997, 94:12088-12093.
215. Power M.R., Peng Y., Maydanski E., Marshall J.S., Lin T.J. The development of early host response to Pseudomonas aeruginosa lung infection is critically dependent on MyD88 in mice. J. Biol. Chem. 2004, (in press).
216. Prévost G., Cribier B., Couppié P., et al. Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities. Infect. Immun. 1995, 63:4121-4129.
217. Quinn M.T., Gauss K.A. Structure and regulation of the neutrophil respiratory burst oxidase: comparison with nonphagocyte oxidases. J. Leukoc. Biol. 2004, 76:760-781.
218. Ramarao N., Gray-Owen S.D., Backert S., Meyer T. Helicobacter pylori inhibits phagocytosis by professional phagocytes involving type IV secretion components. Mol. Microbiol. 2000, 37:1389-1404.
219. Raveh D., Kruskal B.A., Farland J., Ezekowitz R.A.B. Th1 and Th2 cytokines cooperate to stimulate mannose-receptor-mediated phagocytosis. J. Leukoc Biol. 1998, 64:108-113.
220. Re F., Strominger J.L. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J. Biol. Chem. 2001, 276:37692-37699.
221. Riches D.W. Peroxisome proliferator-active receptor γ: A legitimate target to control pulmonary inflammation?. Am. J. Respir. Crit. Care. Med. 2004, 169:145-146.
222. Romani L., Puccetti P., Bistoni F. Interleukin-12 in infectious diseases. Clin. Microbiol. Rev. 1997, 10:611-636.
223. Ruckdeschel K., Pfaffinger G., Haase R., Sing A., Weighardt H., Häcker G., Holzmann B., Heesemann J. Signaling of apoptosis through TLRs critically involves Toll/IL-1 receptor domain-containing adapter inducing IFN&, but not MyD88, in Bacteria-Infected murine macrophages. J. Immunol. 2004, 173:3320-3328.
224. Sabroe I., Jones E.C., Usher L.R., Whyte K.B.M., Dower S.K. Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: A critical role for monocytes in leukocyte lipopolysaccharide responses. J. Immunol. 2002, 168:4701-4710.
225. Saloga J., Leung D.Y., Reardon C., Giorno R.C., Born W., Gelfand E.W. Cutaneous exposure to the superantigen staphylococcal enterotoxin B elicits a T cell-dependent inflammatory response. J. Invest. Dermatol. 1996, 106:982-988.
226. Schaffner A., King C.C., Schaer D., Guiney D.G. Induction and antimicrobial activity of platelet basic protein derivatives in human monocytes. J. Leukoc. Biol. 2004, 76:1010-1018.
227. Schiavo G., van der Goot F.G. The bacterial toxin toolkit. Nat. Rev. Mol. Cell. Biol. 2001, 2:530-537.
228. Schmidt K.D., Tümmler B., Römling U. Com parative genome mapping of Pseudomonas aeruginosa PAO with P. aeruginosa C, which belongs to a major clone in cystic fibrosis patients and aquatic habitats. J. Bacteriol. 1996, 178:85-93.
229. Selbach M., Moese S., Backert S., Jungblut P.R., Meyer T.F. The Helicobacter pylori CagA protein induces tyrosine dephosphorylation of ezrin. Proteomics 2004, 4:2961-2968.
230. Selbach M., Moese S., Hurwitz R., Hauck C.R., Meyer T.F., Backert S. The Helicobacter pylori CagA protein induces cortactin dephosphorylation and actin rearrangement by c-Src inactivation. EMBO J. 2003, 22:515-528.
231. Selbach M., Moese S., Meyer T.F., Backert S. Functional analysis of the Helicobacter pylori cag pathogenicity island reveals both VirD4-CagA-dependent and VirD4-CagA-independent mechanisms. Infect. Immun. 2002, 70:665-671.
232. Shimazu R., Akashi S., Ogata H., Nagai Y., Fukudome K., Miyake K., Kimoto M. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 1999, 189:1777-1782.
233. Shortman K., Wu L. Are dendritic cells and cells?. Nat. Immunol. 2004, 5:1105-1106.
234. Silverman E.S., Drazen J.M. Immunostimulatory DNA for asthma better than eating dirt?. Am J Respir Cell Mol Biol. 2003, 28:645-647.
235. Silverman N., Fitzgerald K. DUBbing down innate immunity. Nat. Immunol. 2004, 5:1010-1012.
236. Silverman G.J. B-cell superantigens. Immunol. Today 1997, 18:379-386.
237. Singer M., Sansonetti P.J. IL-8 is a key chemokine regulating neutrophil recruitment in a new mouse model of Shigella-induced colitis. J. Immunol. 2004, 173:4197-4206.
238. + T cell immunity. Nat. Immunol. 2004, 5:1143-1148.
239. Soman A., Honeybourne D., Andrews J., Jevons G., Wise R. Concentrations of moxifloxacin in serum and pulmonary compartments following a single 400 mg oral dose in patients undergoing fiber-optic bronchoscopy. J. Antimicrob. Chemother. 1999, 44:835-838.
240. Soong G., Reddy B., Sokol S., Adamo R., Prince A. TLR2 is mobilized into an apical lipid raft receptor complex to signal infection in airway epithelial cells. J. Clin. Invest. 2004, 113:1482-1489.
241. Speert D.P., Goldberg J.B. Burkholderia cepacia complex and cystic fibrosis In search of the smoking gun. Am. J. Respir. Crit. Care. Med. 2004, 170:6-7.
242. Stevenson N.J., Haan S., McClurg A.E., Mc Grattan M.J., Armstrong M.A., Heinrich P.C., Johnston J.A. The chemoattractants, IL-8 and Formyl-Methionyl-Leucyl-Phenylalanine, regulate granulocyte colony-stimulating factor signaling by inducing suppressor of cytokine signaling-1 expression. J. Immunol. 2004, 173:3243-3249.
243. Stock P., Akbari O., Berry G., Freeman G.J., DeKruyff R.H., Umetsu D.T. Induction of T-helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity. Nat. Immunol. 2004, 5:1149-1156.
244. Strieter R.M., Belperio J.A., Keane M.P. Host innate defenses in the lung: the role of cytokines. Curr. Opin. Infect. Dis. 2003, 6:193-198.
245. Struck A., Forster J., Ihorst G., Werchau H., König W., König B. Respiratory syncytial virus: G-gene genotype and disease severity. Ped. Inf. Dis. J. 2004, in press.
246. Sundrud M.S., Torres V.J., Unutmaz D., Cover T.L. Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. Proc. Nat. Acad. Sci. USA 2004, 101:7727-7732.
247. Svanborg C., Godaly G., Hedlund M. Cylokine responses during mucosal infections: role in disease pathogenesis and host defense. Curr. Opin. Microbiol. 1999, 2:99-105.
248. Taggart C., Coakley R.J., Greally P., Canny G., O'Neill S.J., McElvaney N.G. Increased elastase release by CF neutrophils is mediated by tumor necrosis factor-alpha and interleukin-8. Am. J. Physiol. Lung. Cell. Mol. Physiol. 2000, 278:L33-L41.
249. Takeuchi O., Hoshino K., Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 2000, 165:5392-5396.
250. Tiemersma E.W., Bronzwaer St., Lyytikäinen O., Degener J.E., Schrijnemakers P., Bruinsma N., Monen J., Witte W., Grundmann H. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg. Inf. Dis. 2004, 10:1627-1634.
251. Tomita T., Kamio Y. Molecular biology of the pore-forming cytolysins from Staphylococcus aureus, alpha- and gamma-hemolysins, and leukocidin. Biosci. Biotechnol. Biochem. 1997, 61:565-572.
252. Tran Van Nhieu G., Clair C., Grompone G., Sansonetti P. Calcium signaling during cell interactions with bacterial pathogens. Biol. Cell. 2004, 96:93-101.
253. Trinchieri G. Immunobiology of interleukin-12. Immunol. Res. 1998, 17:269-278.
254. Trotha R., Reichl U., Thies F.L., Sperling D., König W., König B. Adaption of a fragment analysis technique to an automated high-throughput multicapillary electrophoresis device for the precise qualitative and quantitative characterization of microbial communities. Electrophoresis 2002, 23:1070-1079.
255. Tsai W.C., Strieter R.M., Mehrad B., Newstead M.W., Zeng X., Standiford T.J. CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia. Infect. Immun. 2000, 68:4289-4296.
256. + T cell responses to bacterial antigens. J. Immunol. 2004, 173:1994-2002.
257. Uehara A., Sugawara Y., Sasano T., Takada H., Sugawara S. Pro-inflammatory cytokines induce proteinase 3 as membrane-bound and secretory forms in human oral epithelial cells and antibodies to proteinase 3 activate the cells through protease-activated receptor-2. J. Immunol. 2004, 173:4179-4189.
258. Van Vlem B., Vanholder R., De Paepe P., Vogelaers D., Ringoir S. Immunomodulating effects of antibiotics: literature review. Infection 1996, 24:275-291.
259. Vandenesch F., Naimi T., Enright M.C., Lina G., Nimmo G.R., Heffernan H., Liassine N., Bes M., Greenland T., Reverdy M.E., Etienne J. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg. Infect. Dis. 2003, 9:978-984.
260. Veldkamp K.E., Heezius H.C.J.M., Verhoef J., Van Strijp J.A.G., van Kessel K.P.M. Modulation of neutrophil chemokine receptors by Staphylococcus aureus supernate. Infect. Immun. 2000, 68:5908-5913.
261. Vergnolle N., Wallace J.L., Bunnett N.W., Hollenberg M.D. Protease-activated receptors in inflammation, neuronal signaling, and pain. Trends Pharmakol. Sci. 2001, 22:146-152.
262. Viala J., Chaput C., Boneca I.G., Cardona A., Girardin S.E., Moran A.P., Athman R., Memet S., Huerre M.R., Coyle A.J., Distefano P.S., Sansonetti P.J., Labigne A., Bertin J., Philpott D.J., Ferrero R.L. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol. 2004, 5:1166-1174.
263. Visintin A., Mazzoni A., Spitzer J.H., Wyllie D.H., Dower S.K., Segal D.M. Regulation of Toll-like receptors in human monocytes and dentritic cells. J. Immunol. 2001, 166:249-255.
264. Vogelmann R., Amieva M.R., Falkow S., Nelson W.J. Breaking into the epithelial apical-junctional complex-news from pathogen hackers. Curr. Opin. Cell. Biol. 2004, 16:86-93.
265. Voyich J.M., Braughton K.R., Sturdevant D.E., Vuong C., Kobayashi S.D., Porcella S.F., Otto M., Musser J.M., DeLeo F.R. Engagement of the pathogen survival response used by Group A Streptococcus to avert destruction by innate host defense. J. Immunol. 2004, 173:1194-1201.
266. Waldvogel F.A., Bisro A.L. Infections Associated with Indwelling Medical Devices 2000, ASM Press, Washington, D.C. 3 ed.
267. Wang J., Brooks E.G., Bamford K.B., Denning T.L., Pappo J., Ernst P.B. Negative selection of T cells by Helicobacter pylori as a model for bacterial strain selection by immune evasion. J. Immunol. 2001, 167:926-934.
268. Wat D., Doull I. Respiratory virus infections in cystic fibrosis. Pediatr. Respir. Rev. 2003, 4:172-177.
269. Weinrauch Y., Zychlinsky A. The induction of apoptosis by bacterial pathogens. Annu. Rev. Microbiol. 1999, 53:155-187.
270. Wiegers W., Just I., Muller H., Hellwig A., Traub P., Aktories K. Alteration of the cytoskeleton of mammalian cells cultured in vitro by Clostridium botulinum C2 toxin and C3 ADP-ribosyltransferase. Eur. J. Cell. Biol. 1991, 54:237-245.
271. Wolf B.B., Green D.R. Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivation. J. Biol. Chem. 1999, 274:30651-30666.
272. Wong B., Choi Y. Pathways leading to cell death in T cells. Curr. Opin. Immunol. 1997, 9:358-364.
273. Yamamoto M., Sato S., Hemmi H., Sanjo H., Uematsu S., Kaisho T., Hoshino K., Takeuchi O., Kobayashi M., Fujita T., Takeda K., Akira S. Essential role for TIRAP in activation of the signaling cascade shared by TLR2 and TLR4. Nature 2002, 420:324-329.
274. Yao T., Mecsas J., Healy J.I., Falkow S., Chien Y. Suppression of T and B lymphocyte activation by a Yersinia pseudotuberculosis virulence factor, yopH. J. Exp. Med. 1999, 190:1343-1350.
275. Ye G., Barrera C., Fan X., Gourley W.K., Crowe S.E., Ernst P.B., Reyes V.E. Expression of B7-1 and B7-2 co-stimulatory molecules by human gastric epithelial cells: potential role in CD4+ T cell activation during Helicobacter pylori infection. J. Clin. Invest. 1997, 99:1628-1636.
276. Yu H., Head N.E. Persistent infections and immunity in cystic fibrosis. Front. Biosci. 2002, 7:442-457.
277. Yu H., Hanes M., Chrisp C.E., Boucher J.C., Deretic V. Microbial pathogenesis in cystic fibrosis: pulmonary clearance of mucoid Pseudomonas aeruginosa and inflammation in a mouse model of repeated respiratory challenge. Infect. Immun. 1998, 66:280-288.
278. Zhang L., Peeples M.E., Boucher R.C., Collins P.L., Pickles R.J. Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology. J. Virol. 2002, 76:5654-5666.
279. Zhu J., Min B., Hu-Li J., Watson C.J., Grinberg A., Wang Q., Killeen N., Urban J.F., Guo L., Paul W.E. Conditional deletion of Gata3 shows its essential function in Th1-Th2 responses. Nat. Immunol. 2004, 5:1157-1165.
280. Zychlinsky A., Sansonetti P.J. Apoptosis as a proinflammatory event: what can we learn from bacteria-induced cell death?. Trends Microbiol. 1997, 5:201-204.